Erratum: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study (Journal of Neurology (2014) 261 (267-276) DOI: 10.1007/s00415-013-7115-8)
Main Authors: | Gold, R, Comi, G, Palace, J, Siever, A, Gottschalk, R, Bijarnia, M, Von Rosenstiel, P, Tomic, D, Kappos, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Dr. Dietrich Steinkopff Verlag GmbH and Co. KG
2014
|
Similar Items
-
Erratum: Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis (Journal of Neurology (2013) 260 (2016-2022) DOI: 10.1007/s00415-013-6918-y)
by: Wallner-Blazek, M, et al.
Published: (2014) -
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study
by: Gold, R, et al.
Published: (2014) -
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
by: Gold, R, et al.
Published: (2014) -
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
by: Gold, R, et al.
Published: (2014) -
Erratum: Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension (Journal of Neurology (2010) 257 DOI: 10.1007/s00415-010-5499-2)
by: Dhungana, S, et al.
Published: (2010)